Jolt Health Inc. (CSE:JOLT)
Canada flag Canada · Delayed Price · Currency is CAD
0.0900
0.00 (0.00%)
At close: Jul 15, 2025

Jolt Health Company Description

Jolt Health Inc. operates as a licensee of technologies relating to substances and pharmaceutical grade therapeutics in Canada.

It focuses on sexual health, with or without the benefit of CBD, acquired pursuant to various licenses.

The company also offers CannaStrip, an oral muco-adhesive strips enhance the bioavailability of hemp oil extracts and THC, increasing the impact and duration of the health benefits; Arousel Gel, a topical gel infused with CBD and/or THC that increases genital blood flow causing vaginal engorgement/lubrication and clitoral engorgement/sensitivity; and CannaMint, a patent-protected technology that uses orally dissolvable mints to deliver CBD or THC for various conditions.

In addition, it provides female sexual dysfunction supplement, a female sexual desire supplement; ToConceive, a vaginal moisturize; and male enhancement gel with CBD, a topical personal care penile gel.

The company was formerly known as Love Pharma Inc. and changed its name to Jolt Health Inc. in May 2023.

Jolt Health Inc. is headquartered in Vancouver, Canada.

Jolt Health Inc.
CountryCanada
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees41
CEOGerald Tritt

Contact Details

Address:
355 Burrard Street
Vancouver, Alberta V6C 2G8
Canada
Phone604 343 2977
Websitejolt-health.com

Stock Details

Ticker SymbolJOLT
ExchangeCanadian Securities Exchange
Fiscal YearJanuary - December
Reporting CurrencyCAD
SIC Code7371

Key Executives

NamePosition
Gerald Spencer TrittPresident, Chief Executive Officer and Director
Tatiana KovalevaChief Financial Officer